about
Efficacy and patient tolerability of travoprost BAK-free solution in patients with open-angle glaucoma and ocular hypertension.Evaluation of the cytotoxic effects of ophthalmic solutions containing benzalkonium chloride on corneal epithelium using an organotypic 3-D model.Toxicological screeningPrediction of eye irritation potential of surfactant-based rinse-off personal care formulations by the bovine corneal opacity and permeability (BCOP) assay.Critical appraisal of alternative irritation models: three decades of testing ophthalmic pharmaceuticals.Comparison of cytotoxicity in vitro and irritation in vivo for aqueous and oily solutions of surfactants.Eye Irritation Test (EIT) for Hazard Identification of Eye Irritating Chemicals using Reconstructed Human Cornea-like Epithelial (RhCE) Tissue Model.Reconstruction of a human hemicornea through natural scaffolds compatible with the growth of corneal epithelial stem cells and stromal keratocytes.Hyaluronic acid modified chitosan nanoparticles for effective management of glaucoma: development, characterization, and evaluation.Novel rapid in vitro cytotoxicity test on mammalian cells based on an electrochemical measuring method
P2860
Q30435051-1CEFA133-01E5-4A68-A646-8F895C6081FCQ33488096-4CB46506-C5A7-44E0-9205-6A32C7B06A58Q35079846-3EA3B802-04B8-4BC9-B141-6B2CD2B68206Q36596194-05FBEA3D-15E2-4948-B67C-0DC5C24A9A8DQ38357420-A627D945-DAD0-412F-B372-F80539FC7AA9Q38975634-9695F127-B3C4-42BF-800A-62A8E12619FDQ41831439-FED3E4DF-AF0C-4BA7-A228-56C665CD1F25Q42461985-E8E2EDEB-26B0-4107-852A-CBD28D974F03Q43234583-EDB4F948-BB60-4A6E-A4F7-34675DD1980CQ57005163-B477C3A1-2F1F-435C-B56D-43067CCA7EF5
P2860
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
In vitro alternatives for ocular irritation.
@en
type
label
In vitro alternatives for ocular irritation.
@en
prefLabel
In vitro alternatives for ocular irritation.
@en
P2860
P356
P1476
In vitro alternatives for ocular irritation.
@en
P2093
P2860
P304
P356
10.1289/EHP.98106485
P478
106 Suppl 2
P577
1998-04-01T00:00:00Z